Tag: oral

Infosys and Telstra Announce Joint Venture in Australia

Accelerating AI-powered Cloud & Digital transformation for Australian enterprises BENGALURU, India and MELBOURNE, Australia, Aug. 13, 2025 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY),...

High-tech Health for Students: Health-E Commerce® Highlights 10 Ways to Use Flexible Spending Accounts (FSA) and Health Savings Accounts (HSAs) for Digital Healthcare Products...

Tax-free FSA and HSA funds can be used to purchase health devices at FSA Store and HSA Store that treat conditions like acne, diabetes,...

Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform

More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and setting a new...

COLGATE DENTAL VEER ANTHEM LAUNCHED TO EMPOWER KIDS TO BE THEIR OWN HEROES OF ORAL HEALTH

Released close to Independence Day, the anthem is penned by lyricist Swanand Kirkire and composed by Micu Patel Link to the anthem - Colgate Dental...

Greywolf Therapeutics begins dosing of the first treatment to target the antigenic source of autoimmunity

Greywolf starts first trial of GRWD0715, aiming for a functional cure for autoimmunity by targeting its antigenic source.

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model

- The combination of ASC47 low dose with tirzepatide in diet-induced obese (DIO) mice resulted in an 87% greater reduction in...

Artemis Gold Reports Q2 2025 Results Consistent with Guidance: Q2 Production of 50,623 ounces gold and Post-commercial AISC US$805 per ounce, and Announces $700M...

TSXV: ARTG (all amounts in Canadian dollars unless otherwise stated) VANCOUVER, BC, Aug. 12, 2025 /CNW/ - Artemis Gold Inc. (TSXV: ARTG) ("Artemis Gold" or the...

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

• First study participant randomized in Phase 3 CATT1 trial evaluating cadisegliatin for the treatment of type 1 diabetes with data expected in second half of 2026

Terrestrial Energy Selected for DOE Office of Nuclear Energy Advanced Reactor Pilot Program for Accelerated Development

Advanced Reactor Pilot Program launched by DOE to expedite authorization and commercialization of advanced nuclear reactor designs

FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease

— Approximately 500,000 U.S. Patients Are Diagnosed with Non-Cystic Fibrosis Bronchiectasis (NCFB), a Progressive Disease That Can Lead to Permanent Lung Damage — — BRINSUPRI 10...

First Mining Announces 2025 Second Quarter Financial Results and Operating Highlights

VANCOUVER, BC, Aug. 12, 2025 /PRNewswire/ - First Mining Gold Corp. ("First Mining" or the "Company") (TSX: FF) (OTCQX: FFMGF) (FRANKFURT: FMG) reports its second...

First Mining Announces 2025 Second Quarter Financial Results and Operating Highlights

VANCOUVER, BC, Aug. 12, 2025 /CNW/ - First Mining Gold Corp. ("First Mining" or the "Company") (TSX: FF) (OTCQX: FFMGF) (FRANKFURT: FMG) reports its second...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsOral

KENT WORLDWIDE™ Celebrates the Grand Opening of the World’s Best Cat Litter® Manufacturing Facility with a Ribbon-Cutting Event

Sustainable Pharmaceutical Packaging Market to reach USD 270.4 billion by 2031, Wissen Research

BMI Investors Have Opportunity to Lead Badger Meter, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Tag: oral

Infosys and Telstra Announce Joint Venture in Australia

High-tech Health for Students: Health-E Commerce® Highlights 10 Ways to Use Flexible Spending Accounts (FSA) and Health Savings Accounts (HSAs) for Digital Healthcare Products...

Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform

COLGATE DENTAL VEER ANTHEM LAUNCHED TO EMPOWER KIDS TO BE THEIR OWN HEROES OF ORAL HEALTH

Greywolf Therapeutics begins dosing of the first treatment to target the antigenic source of autoimmunity

Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, Demonstrated Greater Efficacy with Tirzepatide than Semaglutide in a Preclinical Model

Artemis Gold Reports Q2 2025 Results Consistent with Guidance: Q2 Production of 50,623 ounces gold and Post-commercial AISC US$805 per ounce, and Announces $700M...

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Terrestrial Energy Selected for DOE Office of Nuclear Energy Advanced Reactor Pilot Program for Accelerated Development

FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease

First Mining Announces 2025 Second Quarter Financial Results and Operating Highlights

First Mining Announces 2025 Second Quarter Financial Results and Operating Highlights

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us